July 16, 2021
The UNC School of Medicine Office of Graduate Education published findings in PLOS Biology showing that graduate students who partake in professional development opportunities unrelated to their lab work did not delay their time to graduation or their rate of manuscript publication.
July 8, 2021
Ed Browne, PhD, assistant professor of medicine, is the principal investigator of a $4-million, 5-year study of the role of cannabis use in HIV latency – one of the main barriers toward curing people with the infection.
July 1, 2021
Damaris Lorenzo, PhD, at the UNC School of Medicine, led the discovery of a new neurodevelopmental syndrome, its underlying genetic basis and molecular mechanisms, both important milestones on the road to create therapeutic strategies.
June 24, 2021
Led by John Batsis, MD, researchers completed a comprehensive review of 315 existing clinical trials of weight loss supplements and therapies, and most of the studies showed the supplements did not produce weight loss among users.
June 24, 2021
Led by Katie Baldwin, PhD, research published in Neuron shows how the loss of the protein hepaCAM drives brain development dysfunction and plays an important role in neurological disorders.
June 23, 2021
UNC School of Medicine scientists led by Aravinda de Silva, PhD, identified the small subpopulation of antibodies in vaccinated children that correlate with protection against dengue fever. This research should help shape better vaccines for one of the most widespread infectious diseases in the world.
June 17, 2021
Led by John Buse, MD, PhD, and Anna Kahkoska, MD, PhD, this analysis showed that GLP1-RA and SGLT2i medication use for type 2 diabetes of hospitalized COVID-19 patients was associated with lower odds of mortality and other adverse outcomes.
June 17, 2021
NC State researchers led by Ke Cheng, PhD, created a therapeutic approach that mimics the receptor that the virus binds to and then traps the virus before it infect cells. UNC School of Medicine’s Jason Lobo, MD, is a co-author on the study.
June 17, 2021
James F. Howard Jr., MD, Distinguished Professor in the UNC Department of Neurology, was principal investigator of the promising phase 3 trial for the experimental drug efgartigimod.
June 15, 2021
Scientists led by UNC School of Medicine researchers Silvia Kreda, PhD, and Rudolph Juliano, PhD, created an improved oligonucleotide therapy strategy with the potential for treating other pulmonary diseases, such as COPD and asthma.
June 15, 2021
This pre-clinical research offers evidence that vaccinating young children could help prevent the spread of COVID-19, limit disease severity, and achieve herd immunity.
May 28, 2021
The UNC School of Medicine lab of Mehmet Kesimer, PhD, discovered MUC5AC is more reliably associated with the manifestation of COPD than another well-known mucus protein, revealing a possible biomarker of disease initiation, prognosis, and therapeutic effectiveness.